Literature DB >> 25728618

Oestrogen hormone receptors in focal nodular hyperplasia.

Manju D Chandrasegaram1,2, Ali Shah1, John W Chen1,3, Andrew Ruszkiewicz4, David S Astill5, Georgina England4, Ravish S Raju3, Eu Ling Neo1,3, Paul M Dolan1, Chuan Ping Tan1, Mark Brooke-Smith1,3, Tom Wilson3, Robert T A Padbury3, Christopher S Worthley1.   

Abstract

BACKGROUND: The role of hormones in focal nodular hyperplasia (FNH) has been investigated with conflicting results.
OBJECTIVE: The aim of this study was to evaluate oestrogen and progesterone receptor immunohistochemical expression in FNH and surrounding normal liver (control material).
METHODS: Biopsy materials from FNH and control tissue were investigated using an immunostainer. Receptor expression was graded as the proportion score (percentage of nuclear staining) and oestrogen receptor intensity score.
RESULTS: Study material included tissue from 11 resected FNH lesions and two core biopsies in 13 patients (two male). Twelve samples showed oestrogen receptor expression. The percentage of nuclear oestrogen receptor staining was <33% in eight FNH biopsies, 34-66% in two FNH biopsies, and >67% in both core biopsies. The better staining in core biopsies relates to limitations of the staining technique imposed by the fibrous nature of larger resected FNH. Control samples from surrounding tissue were available for nine of the resected specimens and all showed oestrogen receptor expression. Progesterone receptor expression was negligible in FNH and control samples.
CONCLUSIONS: By contrast with previous studies, the majority of FNH and surrounding liver in this cohort demonstrated oestrogen receptor nuclear staining. The implications of this for continued oral contraceptive use in women of reproductive age with FNH remain uncertain given the lack of consistent reported growth response to oestrogen stimulation or withdrawal.
© 2015 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728618      PMCID: PMC4430780          DOI: 10.1111/hpb.12387

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  41 in total

1.  A life-threatening complication of focal nodular hyperplasia.

Authors:  J Hardwigsen; J Pons; V Veit; S Garcia; Y P Le Treut
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

2.  Oral contraceptive use and focal nodular hyperplasia of the liver.

Authors:  D Mathieu; H Kobeiter; P Maison; A Rahmouni; D Cherqui; E S Zafrani; D Dhumeaux
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

Review 3.  Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.

Authors:  T Kubota; K Shimizu; T Sonoyama; E Ikeda; H Kurioka; T Ouchi; Y Suyama; Y Hosokawa; H Yamagishi
Journal:  Hepatogastroenterology       Date:  2001 Nov-Dec

4.  [Natural history of focal nodular hyperplasia. A retrospective study of 44 cases].

Authors:  V D'halluin; V Vilgrain; G Pelletier; L Rocher; J Belghiti; S Erlinger; C Buffet
Journal:  Gastroenterol Clin Biol       Date:  2001-11

5.  Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.

Authors:  K R Reddy; S Kligerman; J Levi; A Livingstone; E Molina; D Franceschi; S Badalamenti; L Jeffers; A Tzakis; E R Schiff
Journal:  Am Surg       Date:  2001-02       Impact factor: 0.688

6.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

Authors:  A Luciani; H Kobeiter; P Maison; D Cherqui; E-S Zafrani; D Dhumeaux; D Mathieu
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study.

Authors:  Astrid Scalori; Alessandra Tavani; Silvano Gallus; Carlo La Vecchia; Massimo Colombo
Journal:  Am J Obstet Gynecol       Date:  2002-02       Impact factor: 8.661

8.  Symptomatic focal nodular hyperplasia during pregnancy: a case report.

Authors:  Valerie Byrnes; Andrés Cárdenas; Nezam Afdhal; Douglas Hanto
Journal:  Ann Hepatol       Date:  2004 Jan-Mar       Impact factor: 2.400

9.  Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis.

Authors:  Valérie Vilgrain; Florence Uzan; Giuseppe Brancatelli; Michael P Federle; Magali Zappa; Yves Menu
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

Review 10.  A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management.

Authors:  Frederick C Cobey; Ronald R Salem
Journal:  Am J Surg       Date:  2004-02       Impact factor: 2.565

View more
  4 in total

1.  Compression of cystic duct caused by focal nodular hyperplasia.

Authors:  Andreea Bente; Moussa Ouedraogo; Kinjal N Kasbawala; Kristen M Glasgow
Journal:  J Surg Case Rep       Date:  2019-10-10

2.  Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?

Authors:  Ashraf A Ashhab; Ahmad Abu-Sulb; Ju Dong Yang; Mazen Noureddin; Vinay Sundaram; Alexander Kuo; Walid S Ayoub
Journal:  ACG Case Rep J       Date:  2021-01-13

Review 3.  Benign Liver Tumors.

Authors:  Karl J Oldhafer; Victoria Habbel; Katja Horling; Georgios Makridis; Kim Caroline Wagner
Journal:  Visc Med       Date:  2020-08-04

4.  A case of hepatic focal nodular hyperplasia mimicking hepatocellular carcinoma identified on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography.

Authors:  Seckin Bilgic; Haluk Burçak Sayman; Muhammet Sait Sager; Kerim Sonmezoglu
Journal:  World J Nucl Med       Date:  2021-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.